Inventor · disambiguated record
David Burkhart
Also filed as: BURKHART DAVID · BURKHART DAVID J
12 granted patents·9 pending applications·4 citations·filing 2004–2024
83Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA8THE UNIV OF MONTANA6IMCYSE SA3CHILDRENS MEDICAL CENTER2KOCH TAD H2
Top patents by PatentIndex Score
21 records- 0181US12023384B2Immunogenic peptides comprising an MHC class II T cell epitope and a redox motifIMCYSE SA·Filed 2020·Granted Jul 2, 2024·1 cites·10 claims
- 0276US12319709B2Diaryl trehalose compounds and uses thereofTHE UNIV OF MONTANA·Filed 2024·Granted Jun 3, 2025·0 cites·13 claims
- 0375US2024342297A1Novel immunogenic peptidesIMCYSE SA·Filed 2024·Application pending·0 cites
- 0474US11964014B2Vaccine adjuvants based on TLR receptor ligandsTHE UNIV OF MONTANA·Filed 2023·Granted Apr 23, 2024·0 cites·10 claims
- 0572US10646566B2Compositions and usesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted May 12, 2020·1 cites·16 claims
- 0670US2022144833A1Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0770US2022144865A1Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0866US12496340B2Vaccine adjuvants based on TLR receptor ligandsTHE UNIV OF MONTANA·Filed 2020·Granted Dec 16, 2025·0 cites·21 claims
- 0965US8404650B2Methods of treating cancer with doxazolidine and prodrugs thereofKOCH TAD H·Filed 2006·Granted Mar 26, 2013·2 cites·9 claims
- 1062US11207404B2Compositions and usesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Dec 28, 2021·0 cites·6 claims
- 1161US11274115B2Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Mar 15, 2022·0 cites·23 claims
- 1259US11912736B2Diaryl trehalose compounds and uses thereofTHE UNIV OF MONTANA·Filed 2019·Granted Feb 27, 2024·0 cites·19 claims
- 1353US2024325517A1Compositions and methods targeting filamentous bacteriophageTHE UNIV OF MONTANA·Filed 2021·Application pending·0 cites
- 1451US2018228912A1Novel immunogenic peptidesIMCYSE SA·Filed 2015·Application pending·0 cites
- 1549US2023310438A1Tlr7/8 agonists to enhance immune responses in opioid using individualsCHILDRENS MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 1646US9827260B2Composition for buffered aminoalkyl glucosaminide phosphate compounds and its use for enhancing an immune responseGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Nov 28, 2017·0 cites·48 claims
- 1745US11572381B2Immunogenic trehalose compounds and uses thereofTHE UNIV OF MONTANA·Filed 2019·Granted Feb 7, 2023·0 cites·23 claims
- 1845US11464854B2Methods and compositions relating to adjuvantsCHILDRENS MEDICAL CENTER·Filed 2018·Granted Oct 11, 2022·0 cites·19 claims
- 1941US2018318415A1Novel adjuvant formulationsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 2032US2007275911A1Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the SameKOCH TAD H·Filed 2004·Application pending·0 cites
- 2132US2017071967A1Immunogenic liposomal formulationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Burkhart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →